These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31709540)

  • 1. Leukemia stem cell immunophenotyping tool for diagnostic, prognosis, and therapeutics.
    Mastelaro de Rezende M; Ferreira AT; Paredes-Gamero EJ
    J Cell Physiol; 2020 Jun; 235(6):4989-4998. PubMed ID: 31709540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunophenotype characterization of hematopoietic stem cells, progenitor cells restricted to myeloid lineage and their leukemia counterparts.
    Fajtova M; Babusikova O
    Neoplasma; 2010; 57(5):392-400. PubMed ID: 20568892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between the expression of leukemia stem cell immunophenotype and the treatment efficacy and prognosis].
    Zhu HB; Zhao MF; Li YM
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jan; 33(1):58-60. PubMed ID: 22575197
    [No Abstract]   [Full Text] [Related]  

  • 4. Flow cytometric quantification and immunophenotyping of leukemic stem cells in acute myeloid leukemia.
    Hwang K; Park CJ; Jang S; Chi HS; Kim DY; Lee JH; Lee JH; Lee KH; Im HJ; Seo JJ
    Ann Hematol; 2012 Oct; 91(10):1541-6. PubMed ID: 22669506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High GPR56 surface expression correlates with a leukemic stem cell gene signature in CD34-positive AML.
    Daga S; Rosenberger A; Quehenberger F; Krisper N; Prietl B; Reinisch A; Zebisch A; Sill H; Wölfler A
    Cancer Med; 2019 Apr; 8(4):1771-1778. PubMed ID: 30848055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding of leukemic stem cells and their clinical implications.
    Wang X; Huang S; Chen JL
    Mol Cancer; 2017 Jan; 16(1):2. PubMed ID: 28137304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a hierarchy in human acute myeloid leukemia progenitor cells.
    Sutherland HJ; Blair A; Zapf RW
    Blood; 1996 Jun; 87(11):4754-61. PubMed ID: 8639846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective immunophenotyping for diagnosis of B-cell neoplasms: immunohistochemistry and flow cytometry strategies and results.
    Boyd SD; Natkunam Y; Allen JR; Warnke RA
    Appl Immunohistochem Mol Morphol; 2013 Mar; 21(2):116-31. PubMed ID: 22820658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis and Isolation of Mouse Leukemic Stem Cells.
    Dong F; Bai H; Ema H
    Methods Mol Biol; 2021; 2185():51-63. PubMed ID: 33165842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted elimination of leukemia stem cells; a new therapeutic approach in hemato-oncology.
    ten Cate B; de Bruyn M; Wei Y; Bremer E; Helfrich W
    Curr Drug Targets; 2010 Jan; 11(1):95-110. PubMed ID: 20017722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD45
    Heo SK; Noh EK; Ju LJ; Sung JY; Jeong YK; Cheon J; Koh SJ; Min YJ; Choi Y; Jo JC
    BMC Cancer; 2020 Apr; 20(1):285. PubMed ID: 32252668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell molecular analysis defines therapy response and immunophenotype of stem cell subpopulations in CML.
    Warfvinge R; Geironson L; Sommarin MNE; Lang S; Karlsson C; Roschupkina T; Stenke L; Stentoft J; Olsson-Strömberg U; Hjorth-Hansen H; Mustjoki S; Soneji S; Richter J; Karlsson G
    Blood; 2017 Apr; 129(17):2384-2394. PubMed ID: 28122740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: patient-subgroups, prognostic impact, and technical aspects.
    Culen M; Borsky M; Nemethova V; Razga F; Smejkal J; Jurcek T; Dvorakova D; Zackova D; Weinbergerova B; Semerad L; Sadovnik I; Eisenwort G; Herrmann H; Valent P; Mayer J; Racil Z
    Oncotarget; 2016 May; 7(22):33016-24. PubMed ID: 27145281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukemia stem cells.
    Luo L; Han ZC
    Int J Hematol; 2006 Aug; 84(2):123-7. PubMed ID: 16926133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow Cytometry Assessment of CD26
    Raspadori D; Pacelli P; Sicuranza A; Abruzzese E; Iurlo A; Cattaneo D; Gozzini A; Galimberti S; Baratè C; Pregno P; Nicolosi M; Sorà F; Annunziata M; Luciano L; Caocci G; Moretti S; Sgherza N; Fozza C; Russo S; Usala E; Liberati MA; Ciofini S; Trawinska MM; Gozzetti A; Bocchia M
    Cytometry B Clin Cytom; 2019 Jul; 96(4):294-299. PubMed ID: 30714299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of acute myelogenous leukemia stem cell properties after treatment and progression.
    Ho TC; LaMere M; Stevens BM; Ashton JM; Myers JR; O'Dwyer KM; Liesveld JL; Mendler JH; Guzman M; Morrissette JD; Zhao J; Wang ES; Wetzler M; Jordan CT; Becker MW
    Blood; 2016 Sep; 128(13):1671-8. PubMed ID: 27421961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biology and relevance of human acute myeloid leukemia stem cells.
    Thomas D; Majeti R
    Blood; 2017 Mar; 129(12):1577-1585. PubMed ID: 28159741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progress in the leukemic stem cell study and a novel therapeutic approach targeting leukemic stem cells].
    Kikushige Y; Miyamoto T; Akashi K
    Rinsho Ketsueki; 2017; 58(10):1838-1843. PubMed ID: 28978822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
    Al-Mawali A; Gillis D; Lewis I
    J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic alteration of bone marrow HSC and microenvironmental association in experimentally induced leukemia.
    Basak P; Chatterjee S; Das M; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
    Curr Stem Cell Res Ther; 2010 Dec; 5(4):379-86. PubMed ID: 20528754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.